Pharvaris vs Sensorion

Pharvaris logo

Pharvaris

Pioneering science for patient choice

168 employees · est. 2015 · Zug, Switzerland

VS
Sensorion logo

Sensorion

Our mission: find solutions for hearing disorders

85 employees · est. 2009 · Montpellier, France

Sensorion is the older company (2015 vs 2009).

Side-by-Side Comparison

Pharvaris Sensorion
Founded
2015 2009 older
Headquarters
Zug, Switzerland Montpellier, France
Employees
168 85
Industry
Biotechnology, Health Care, Life Sciences Biopharma, Biotechnology, Health Care
Funding Stage
IPO Post-IPO Equity
Total Funding
$967.33M $98.25M
Funding Rounds
8 5
Services
Development of oral bradykinin B2 receptor antagonists, Research and clinical trials for hereditary and acquired angioedema, Providing oral alternatives to traditional injection therapies Not tracked yet
Target Customers
Patients with hereditary angioedema (HAE), Patients with acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), Healthcare providers managing bradykinin-mediated conditions Not tracked yet
Taxonomy
Clinical-stage BiotechnologyBradykinin-B2-Receptor AntagonistsOral Therapeutics DevelopmentRare DisordersHereditary AngioedemaSmall Molecule Drug Discovery +8 Clinical-stage DevelopmentTherapeutic SolutionsHearing DisordersGene TherapyMonogenic DeafnessInner Ear Disorders +8
Website
pharvaris.com sensorion.com
Pharvaris logo

About Pharvaris

Pharvaris, founded in 2015, is a Switzerland-based clinical-stage company at the forefront of developing oral treatments for bradykinin-mediated diseases such as hereditary angioedema (HAE). The company’s slogan, "Pioneering science for patient choice", reflects its dedication to innovative therapeu...

Sensorion logo

About Sensorion

Sensorion is a clinical-stage biotechnology company founded in 2009, with a mission to find solutions for hearing disorders. The company's clinical-stage portfolio includes SENS-401 (Arazasetron), a Phase 2 product being studied in Cisplatin-Induced Ototoxicity (CIO) and in patients scheduled for co...

Also comparing in this category

Comparing more than these two?

Get Pharvaris, Sensorion and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Pharvaris compare?

A PDF of Pharvaris and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Pharvaris was founded in 2015, based in Zug, Switzerland, with 168 employees. Pharvaris, founded in 2015, is a Switzerland-based clinical-stage company at the forefront of developing oral treatments for bradykinin-mediated diseases such as hereditary angioedema (HAE). The compa. Sensorion was founded in 2009, based in Montpellier, France, with 85 employees. Sensorion is a clinical-stage biotechnology company founded in 2009, with a mission to find solutions for hearing disorders. The company's clinical-stage portfolio includes SENS-401 (Arazasetron), a P.
Pharvaris has raised $967.33M and Sensorion $98.25M. Latest stage: Pharvaris IPO, Sensorion Post-IPO Equity.
Both work in Biotechnology and Health Care.

Compare Pharvaris with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Pharvaris on 1 Apr 2026, and Sensorion on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes